ClassID:

111466

C12N2770/32034 - CPC Classification

Classification description:

ssRNA viruses positive-sense; Details; Picornaviridae Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Recent Application in this class:
#1
20250101066
2025-03-27

Viral Vaccines

#2
20250084132
2025-03-13

T-CELL EPITOPE POLYPEPTIDE OF SENECAVIRUS A AND USES THEREOF

#3
20250018024
2025-01-16

COMPOSITIONS AND METHODS FOR PROTEIN EXPRESSION WITH RNA

#4
20250009867
2025-01-09

COXSACKIEVIRUS B4 STRAIN AND APPLICATION THEREOF

#5
20240197855
2024-06-20

Foot-and-mouth disease vaccine

#6
20240024452
2024-01-25

CANCER IMMUNOTHERAPY USING VIRUS PARTICLES

#7
20230024508
2023-01-26

Cancer immunotherapy using virus particles

#8
20220249650
2022-08-11

SENECAVIRUS A VIRUS STRAINS AND IMMUNOGENIC COMPOSITIONS THEREFROM

#9
20220233700
2022-07-28

PHARMACEUTICAL COMPOSITION CONTAINING STABILIZED NUCLEIC ACID ADJUVANT

#10
20220088173
2022-03-24

Foot-and-mouth disease vaccine

#11
20220031832
2022-02-03

Recombinant nucleic acid of Seneca valley virus, recombinant vaccine strain and preparation method and use thereof

#12
20210162040
2021-06-03

Triple vaccine against and avian encephalomyelitis virus and fowl pox virus

#13
20210052717
2021-02-25

Cancer immunotherapy using virus particles

#14
20200317739
2020-10-08

Recombinant polypeptides derived from FBP1 and FBP2 and uses of the same

#15
20200306362
2020-10-01

Senecavirus a immunogenic compositions and methods thereof

#16
20200172878
2020-06-04

Attenuated porcine sapelovirus strain and immunogenic compositions therefrom

#17
20200078456
2020-03-12

Foot-and-mouth disease vaccine

#18
20190359964
2019-11-28

Modified foot-and-mouth disease virus 3C proteases and methods for processing FMDV P1 precursor polypeptide

#19
20190350990
2019-11-21

Virus-like particle of Senecavirus A

#20
20190076519
2019-03-14

Immunogenic rhinovirus peptides

#21
20180371026
2018-12-27

Feline calicivirus vaccine

#22
20180305422
2018-10-25

Recombinant polypeptides derived from FBP1 and FBP2 and uses of the same

#23
20180264101
2018-09-20

Foot-and-mouth disease vaccine

#24
20180243399
2018-08-30

FCV recombinant vaccines and uses thereof

#25
20180214538
2018-08-02

Generation of antibodies to tumor antigens and generation of tumor specific complement dependent cytotoxicity by administration of oncolytic vaccinia virus

#26
20180133304
2018-05-17

Cancer immunotherapy using virus particles

#27
20180057541
2018-03-01

antigens and methods of use

#28
20170151322
2017-06-01

Cell lines for virus production and methods of use

#29
20160022803
2016-01-28

Vaccine

#30
20150374812
2015-12-31

CELL LINES FOR VIRUS PRODUCTION AND METHODS OF USE

#31
20150037355
2015-02-05

Generation of antibodies to tumor antigens and generation of tumor specific complement dependent cytotoxicity by administration of oncolytic vaccinia virus

#32
20130236487
2013-09-12

Designer peptide-based PCV2 vaccine

#33
20120237543
2012-09-20

Equine rhinitis vaccine

#34
20110150770
2011-06-23

MULTIVALENT VACCINE AGAINST PORCINE TESCHOVIRUS AND OTHER DISEASE CAUSING ORGANISMS IN SWINE

#35
20090041795
2009-02-12

Synthetic replikin peptides against pathogenic infection of invertebrates in aquaculture